LipoxinA4 analog BML-111 protects podocytes cultured in high-glucose medium against oxidative injury via activating Nrf2 pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LipoxinA4 analog BML-111 protects podocytes cultured in high-glucose medium against oxidative injury via activating Nrf2 pathway

Published:2022-10 Issue: Volume:111 Page:109170
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Hao Hua,Xie Fangping,Xu Fen,Wang Qingyu,Wu Yun,Zhang Dongxin

Funder

Tongji University

Shanghai Municipal Health Commission

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference22 articles.

1. Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?;Gallagher;Diabetes Obes. Metab.,2016

2. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis;Ioannou;Hormones (Athens, Greece),2017

3. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis;Talalay;Adv. Enzyme Regul.,2003

4. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds;Jeong;Antioxid. Redox Signal.,2006

5. The KEAP1-NRF2 System in Cancer;Taguchi;Front. Oncol.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Prediction of Cyclic Peptide Structural Ensembles and Application to the Design of Keap1 Binders;Journal of Chemical Information and Modeling;2023-11-02

2. Promising Anti-Inflammatory Tools: Biomedical Efficacy of Lipoxins and Their Synthetic Pathways;International Journal of Molecular Sciences;2023-08-27

3. Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease;Free Radical Biology and Medicine;2023-07

4. Nuclear Factor Erythroid 2-Related Factor 2 Versus Reactive Oxygen Species: Potential Therapeutic Approach on Fighting Liver Fibrosis;Open Access Macedonian Journal of Medical Sciences;2023-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3